NanoViricides, Inc.
NNVC · AMEX
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Cost of Goods Sold | $133 | $0 | $0 | $0 |
| Gross Profit | -$133 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| R&D Expenses | $993 | $1,177 | $1,282 | $1,156 |
| G&A Expenses | $0 | $938 | $967 | $903 |
| SG&A Expenses | $671 | $938 | $967 | $903 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $1,664 | $2,116 | $2,249 | $2,059 |
| Operating Income | -$1,797 | -$2,116 | -$2,249 | -$2,059 |
| % Margin | – | – | – | – |
| Other Income/Exp. Net | $12 | $20 | $32 | $32 |
| Pre-Tax Income | -$1,785 | -$2,096 | -$2,217 | -$2,027 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$1,785 | -$2,096 | -$2,217 | -$2,027 |
| % Margin | – | – | – | – |
| EPS | -0.1 | -0.13 | -0.14 | -0.14 |
| % Growth | 23.1% | 7.1% | 0% | – |
| EPS Diluted | -0.1 | -0.13 | -0.14 | -0.14 |
| Weighted Avg Shares Out | 17,082 | 16,512 | 16,026 | 14,572 |
| Weighted Avg Shares Out Dil | 17,082 | 16,512 | 16,026 | 14,572 |
| Supplemental Information | – | – | – | – |
| Interest Income | $12 | $20 | $32 | $32 |
| Interest Expense | – | $0 | $0 | $0 |
| Depreciation & Amortization | $133 | $161 | $191 | $196 |
| EBITDA | -$1,652 | -$1,935 | -$2,026 | -$1,831 |
| % Margin | – | – | – | – |